CML: Molecular Oncology Tumor Boards

This free activity is part of the Molecular Oncology Tumor Board series, which is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).

Join the discussion now on the ASCO Connection

Make sure to click on the “Follow this Conversation” option at the bottom of the screen to be notified with case updates and user commentary.

The discussion forum will be open to commentary from February 15, 2017 through March 1, 2017. Users will have the opportunity to review the discussion and claim CME credit from this page by March 1 2017.